A0336: Prognostic value of fat loss in patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint inhibition

Dr. J. (Jihwan) Lee

Lee J.¹, Lee S.M.¹, Lee J.H.², Hwang S.³, Jee B.⁴, Kim J.⁵, Chung J.H.⁶, Song W.⁶, Sung H.H.⁶, Jeon H.G.⁶, Jeong B.C.⁶, Seo S.I.⁶, Jeon S.S.⁶, Lee H.M.⁶, Park S.H.⁷, Kwon G.Y.⁸, Kang M.¹

¹Samsung Medical Center, Dept. of Urology, Seoul, South Korea, ²Samsung Medical Center, Dept. of Radiology, Seoul, South Korea, ³Samsung Medical Center, Dept. of Pathology, Seoul, South Korea, ⁴Sungkyunkwan University School of Medicine, Dept. of Urology, Seoul, South Korea, ⁵Samsung Medical Center, Dept. of Radiology and Center for Imaging Sciences, Seoul, South Korea, ⁶Sungkyunkwan University of Medicine, Dept. of Urology, Seoul, South Korea, ⁷Sungkyunkwan University of Medicine, Dept. of Medical Oncology, Seoul, South Korea, ⁸Samsung Medical Center, Dept. of Pathology and Translational Genomics, Seoul, South Korea